Reivell, Veronica
Hagman, Helga
Haux, Johan
Jorns, Carl
Lindnér, Per
Taflin, Helena http://orcid.org/0000-0002-8795-5250
Funding for this research was provided by:
Cancerfonden (20 1130)
University of Gothenburg
Article History
Received: 6 July 2022
Accepted: 21 September 2022
First Online: 30 September 2022
Declarations
:
: The study has been approved by the Swedish Ethical Review Authority Dnr: 2019-02494.
: In the SOULMATE trial, no specific consent for publication will be used. In the consent form, it is declared that results will be published in peer-reviewed scientific journals. Results will be published in groups, and no identifying images and personal or clinical details of participants will be presented.
: The authors declare that they have no competing interests.